# SOCS5

## Overview
Suppressor of Cytokine Signaling 5 (SOCS5) is a gene that encodes a protein belonging to the SOCS family, which plays a crucial role in the negative regulation of cytokine signaling pathways. The SOCS5 protein is characterized by a central Src homology 2 (SH2) domain and a C-terminal SOCS box, which are essential for its function as a regulatory protein. The SH2 domain facilitates binding to phosphorylated tyrosine residues on signaling intermediates, while the SOCS box is involved in forming an E3 ubiquitin ligase complex that targets proteins for degradation (Feng2011The; Babon2009The). SOCS5 is particularly significant in modulating the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, where it acts as a negative feedback regulator by inhibiting JAK1 and JAK2 kinases (Linossi2013Suppressor). Additionally, SOCS5 interacts with the epidermal growth factor receptor (EGFR) and plays a protective role in viral infections, such as influenza, by modulating signaling pathways that influence viral replication and immune responses (Kedzierski2017Suppressor). The gene's expression and function have implications in various diseases, including chronic obstructive pulmonary disorder (COPD) and nephrotic syndrome, highlighting its clinical significance in inflammatory and immune-related conditions (OstalskaNowicka2012SOCS3; Sobah2021SOCS).

## Structure
SOCS5 is a member of the suppressor of cytokine signaling (SOCS) family, characterized by a central SH2 domain and a C-terminal SOCS box. The SH2 domain is involved in binding phosphorylated tyrosine residues on signaling intermediates, facilitating protein-protein interactions (Feng2011The; Babon2009The). The SOCS box is crucial for forming an E3 ubiquitin ligase complex, which targets proteins for degradation by interacting with elonginBC and Cullin5 (Babon2009The). This interaction is essential for the ubiquitination and subsequent proteasomal degradation of target proteins (Babon2009The).

The N-terminal domain of SOCS5 is largely disordered, enriched in flexible amino acids, and contains short ordered regions, including a structured segment of 15-20 residues (Feng2011The). This domain is implicated in interactions with receptors such as the epidermal growth factor receptor and interleukin-4 receptor (Feng2011The). The N-terminal domain also contains a conserved motif unique to SOCS4, SOCS5, and related proteins in lower vertebrates (Feng2011The).

SOCS5 is expressed as two mRNA species of 3.5 and 4.5 kb, suggesting the existence of splice variant isoforms, which may influence its function and interactions (Hilton1998Twenty).

## Function
SOCS5 (Suppressor of Cytokine Signaling 5) is a protein involved in regulating cytokine signaling pathways, primarily through its role as a negative feedback regulator of the JAK/STAT pathway. In healthy human cells, SOCS5 inhibits the activation of JAK1 and JAK2 kinases, which are crucial for cytokine receptor signaling. This inhibition is mediated by a conserved region in the SOCS5 N-terminus, known as the JAK interaction region (JIR), which directly interacts with the JAK kinases to prevent their autophosphorylation (Linossi2013Suppressor).

SOCS5 also interacts with the epidermal growth factor receptor (EGFR) and negatively regulates EGFR signaling pathways, which are important for cell growth and differentiation. This regulation is achieved through SOCS5's ability to bind to specific phosphorylated peptides, such as those in the Shc-1 protein, thereby modulating downstream signaling events (Linossi2013Suppressor).

In the context of influenza virus infection, SOCS5 plays a protective role by modulating signaling pathways that influence susceptibility to infection. It restricts viral replication in the airway epithelium by inhibiting EGFR and PI3K signaling, which are critical for viral entry and replication (Kedzierski2017Suppressor).

## Clinical Significance
SOCS5 has been implicated in various diseases and conditions due to its role in cytokine signaling. Alterations in SOCS5 expression have been associated with increased susceptibility to influenza virus infection. In SOCS5-deficient mice, there is an increase in viral titres and heightened pro-inflammatory cytokines, particularly IL-6 and G-CSF, leading to increased neutrophils and enhanced weight loss. This suggests that SOCS5 plays a critical role in regulating immune responses during viral infections (Sobah2021SOCS).

In the context of chronic obstructive pulmonary disorder (COPD), SOCS5 levels are decreased, which is associated with enhanced pro-inflammatory signaling through cytokines such as IL-1β and TNF-α. This indicates that SOCS5 may have a protective role against excessive inflammation in COPD (Sobah2021SOCS).

SOCS5 expression is also relevant in nephrotic syndrome (NS) in children. Increased SOCS5 mRNA expression has been observed in steroid-resistant nephrotic syndrome (SRNS) patients after glucocorticosteroid treatment, suggesting its potential as a biomarker for predicting steroid response in NS (OstalskaNowicka2012SOCS3). These findings highlight the clinical significance of SOCS5 in various inflammatory and immune-related conditions.

## Interactions
Suppressor of Cytokine Signaling 5 (SOCS5) is involved in several protein interactions that regulate signaling pathways. SOCS5 interacts with the Janus kinase (JAK) family, specifically inhibiting JAK1 and JAK2 activation through its N-terminal region, known as the JAK interaction region (JIR). This region is crucial for SOCS5's ability to inhibit JAK1 phosphorylation, as its deletion results in a complete loss of this inhibitory function (Linossi2013Suppressor). SOCS5 also binds directly to the JAK1 JH1 domain, with a strong binding affinity, and can interact with JAK3 and TYK2, although it does not inhibit these kinases (Linossi2013Suppressor).

SOCS5 interacts with the adaptor protein Shc-1, specifically binding to the phosphoTyr317 site through its SH2 domain. This interaction suggests a role in regulating Ras/MAPK signaling pathways and potentially in oncogenic signaling due to increased Shc-1 phosphorylation (Linossi2013Suppressor). SOCS5's interaction with Shc-1 is significant as it may influence EGF and growth factor signaling pathways (Linossi2013Suppressor).

In the context of influenza infection, SOCS5 interacts with PI3K subunits in a phosphorylation-dependent manner, suggesting a role in modulating EGFR and PI3K signaling complexes, which are crucial for controlling viral replication and inflammatory responses (Kedzierski2017Suppressor).


## References


[1. (OstalskaNowicka2012SOCS3) Danuta Ostalska-Nowicka, Magdalena Smiech, Malgorzata Jaroniec, Katarzyna Zaorska, Piotr Zawierucha, Witold Szaflarski, Agnieszka Malinska, and Michal Nowicki. Socs3 and socs5 mrna expressions may predict initial steroid response in nephrotic syndrome children. Folia Histochemica et Cytobiologica, 49(4):719–728, January 2012. URL: http://dx.doi.org/10.5603/fhc.2011.0096, doi:10.5603/fhc.2011.0096. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.5603/fhc.2011.0096)

[2. (Feng2011The) Zhi‐Ping Feng, Indu R. Chandrashekaran, Andrew Low, Terence P. Speed, Sandra E. Nicholson, and Raymond S. Norton. The n‐terminal domains of socs proteins: a conserved region in the disordered n‐termini of socs4 and 5. Proteins: Structure, Function, and Bioinformatics, 80(3):946–957, December 2011. URL: http://dx.doi.org/10.1002/prot.23252, doi:10.1002/prot.23252. This article has 34 citations.](https://doi.org/10.1002/prot.23252)

[3. (Linossi2013Suppressor) Edmond M. Linossi, Indu R. Chandrashekaran, Tatiana B. Kolesnik, James M. Murphy, Andrew I. Webb, Tracy A. Willson, Lukasz Kedzierski, Alex N. Bullock, Jeffrey J. Babon, Raymond S. Norton, Nicos A. Nicola, and Sandra E. Nicholson. Suppressor of cytokine signaling (socs) 5 utilises distinct domains for regulation of jak1 and interaction with the adaptor protein shc-1. PLoS ONE, 8(8):e70536, August 2013. URL: http://dx.doi.org/10.1371/journal.pone.0070536, doi:10.1371/journal.pone.0070536. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0070536)

[4. (Babon2009The) Jeffrey J. Babon, Jennifer K. Sabo, Jian-Guo Zhang, Nicos A. Nicola, and Raymond S. Norton. The socs box encodes a hierarchy of affinities for cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression. Journal of Molecular Biology, 387(1):162–174, March 2009. URL: http://dx.doi.org/10.1016/j.jmb.2009.01.024, doi:10.1016/j.jmb.2009.01.024. This article has 104 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2009.01.024)

[5. (Sobah2021SOCS) Mohamed Luban Sobah, Clifford Liongue, and Alister C. Ward. Socs proteins in immunity, inflammatory diseases, and immune-related cancer. Frontiers in Medicine, September 2021. URL: http://dx.doi.org/10.3389/fmed.2021.727987, doi:10.3389/fmed.2021.727987. This article has 82 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmed.2021.727987)

[6. (Kedzierski2017Suppressor) Lukasz Kedzierski, Michelle D Tate, Alan C Hsu, Tatiana B Kolesnik, Edmond M Linossi, Laura Dagley, Zhaoguang Dong, Sarah Freeman, Giuseppe Infusini, Malcolm R Starkey, Nicola L Bird, Simon M Chatfield, Jeffrey J Babon, Nicholas Huntington, Gabrielle Belz, Andrew Webb, Peter AB Wark, Nicos A Nicola, Jianqing Xu, Katherine Kedzierska, Philip M Hansbro, and Sandra E Nicholson. Suppressor of cytokine signaling (socs)5 ameliorates influenza infection via inhibition of egfr signaling. eLife, February 2017. URL: http://dx.doi.org/10.7554/eLife.20444, doi:10.7554/elife.20444. This article has 72 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/eLife.20444)

[7. (Hilton1998Twenty) Douglas J. Hilton, Rachael T. Richardson, Warren S. Alexander, Elizabeth M. Viney, Tracy A. Willson, Naomi S. Sprigg, Robyn Starr, Sandra E. Nicholson, Donald Metcalf, and Nicos A. Nicola. Twenty proteins containing a c-terminal socs box form five structural classes. Proceedings of the National Academy of Sciences, 95(1):114–119, January 1998. URL: http://dx.doi.org/10.1073/pnas.95.1.114, doi:10.1073/pnas.95.1.114. This article has 585 citations.](https://doi.org/10.1073/pnas.95.1.114)